Abstract | OBJECTIVE: To estimate the effect of oral midazolam on patient pain and anxiety perception during first-trimester surgical abortion. METHODS: Between May and December 2013, we conducted a randomized, double-blind, placebo-controlled trial. Patients between 6 0/7 and 10 6/7 weeks of gestation received 10 mg oral midazolam or placebo 30-60 minutes before surgical abortion. All patients received ibuprofen and a paracervical block. We powered the study (power=80%; significance level=.025) to detect a 15-mm difference in our two a priori primary outcomes of pain and anxiety with uterine aspiration on a 100-mm visual analog scale. Secondary outcomes were pain and anxiety at additional time points, memory, satisfaction, side effects, and adverse events. RESULTS: Demographics were similar between groups (placebo=62, midazolam=62). Compared with those randomized to placebo, patients who received midazolam had significantly less anxiety preoperatively (room entry: 51.4 mm compared with 34.5 mm, P<.001; positioning: 56.6 mm compared with 45.4 mm, P=.02). There was no difference in pain (P=.28) or anxiety (P=.14) during uterine aspiration or at other procedural time points. A significantly greater number of patients in the midazolam group reported partial amnesia (31/61 compared with 16/61, P=.005) and dizziness (30/61 compared with 18/61, P=.03). Controlling for baseline differences, patients who received midazolam reported more postoperative sleepiness (P<.001) and less postoperative nausea (P=.004). There was no difference in overall satisfaction (P=.88). CONCLUSION: Although oral midazolam reduces preprocedural anxiety, it does not reduce pain or anxiety with uterine aspiration during first-trimester surgical abortions. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT01830881. LEVEL OF EVIDENCE: I.
|
Authors | Lisa L Bayer, Alison B Edelman, Rongwei Fu, William E Lambert, Mark D Nichols, Paula H Bednarek, Kelsey Miller, Jeffrey T Jensen |
Journal | Obstetrics and gynecology
(Obstet Gynecol)
Vol. 126
Issue 1
Pg. 37-46
(Jul 2015)
ISSN: 1873-233X [Electronic] United States |
PMID | 26241254
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Analgesics
- Anti-Anxiety Agents
- Midazolam
|
Topics |
- Abortion, Induced
(adverse effects, methods, psychology)
- Administration, Oral
- Adolescent
- Adult
- Analgesics
(therapeutic use)
- Anti-Anxiety Agents
(therapeutic use)
- Anxiety
(etiology, prevention & control)
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Linear Models
- Midazolam
(therapeutic use)
- Pain Measurement
- Pain, Postoperative
(diagnosis, prevention & control)
- Pregnancy
- Pregnancy Trimester, First
- Treatment Outcome
- Young Adult
|